Defining Pathways forDevelopment of Disease-Modifying Therapies in Children With Type 1 Diabetes: A Consensus Report

Autor: Gitelman, Stephen, Wherrett, DK, Chiang, JL, Delamater, AM, Dimeglio, LA, Gitelman, SE, Gottlieb, PA, Herold, KC, Lovell, DJ, Orchard, TJ, Ryan, CM

Publikováno v: Gitelman, Stephen; Wherrett, DK; Chiang, JL; Delamater, AM; Dimeglio, LA; Gitelman, SE; et al.(2015). Defining Pathways forDevelopment of Disease-Modifying Therapies in Children With Type 1 Diabetes: A Consensus Report. UC San Francisco: Retrieved from: http://www.escholarship.org/uc/item/4wm074bk

© 2015 by the American Diabetes Association.Emerging data suggest that type 1 diabetes is a more aggressive disease in children than in adults, with important differences in pathophysiology and clinical course. Therefore, the efficacy of disease-mod

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od_______325::415d6446b172fb9a23a3a4079a0180b4
http://www.escholarship.org/uc/item/4wm074bk

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Erratum. Consensus Guidance for Monitoring Individuals With Islet Autoantibody-Positive Pre-Stage 3 Type 1 Diabetes. Diabetes Care 2024;47:1276-1298.

Autor: Phillip M, Achenbach P, Addala A, Albanese-O'Neill A, Battelino T, Bell KJ, Besser REJ, Bonifacio E, Colhoun HM, Couper JJ, Craig ME, Danne T, Beaufort C, Dovc K, Driscoll KA, Dutta S, Ebekozien O, Larsson HE, Feiten DJ, Frohnert BI, Gabbay RA, Gallagher MP, Greenbaum CJ, Griffin KJ, Hagopian W, Haller MJ, Hendrieckx C, Hendriks E, Holt RIG, Hughes L, Ismail HM, Jacobsen LM, Johnson SB, Kolb LE, Kordonouri O, Lange K, Lash RW, Lernmark Å, Libman I, Lundgren M, Maahs DM, Marcovecchio ML, Mathieu C, Miller KM, O'Donnell HK, Oron T, Patil SP, Pop-Busui R, Rewers MJ, Rich SS, Schatz DA, Schulman-Rosenbaum R, Simmons KM, Sims EK, Skyler JS, Smith LB, Speake C, Steck AK, Thomas NPB, Tonyushkina KN, Veijola R, Wentworth JM, Wherrett DK, Wood JR, Ziegler AG, DiMeglio LA

Publikováno v: Diabetes care [Diabetes Care] 2024 Nov 01; Vol. 47 (11), pp. 2033.

Correction to: Consensus guidance for monitoring individuals with islet autoantibody‑positive pre‑stage 3 type 1 diabetes.

Autor: Phillip M; Institute for Endocrinology and Diabetes, National Center for Childhood Diabetes, Schneider Children's Medical Center of Israel, Petah Tikva, Israel.; Faculty of Medical and Health Sciences, Tel Aviv University, Tel Aviv, Israel., Achenbach P; Institute of Diabetes Research, Helmholtz Zentrum Munchen, German Research Center for Environmental Health, Munich‑Neuherberg, Germany.; Forschergruppe Diabetes, Technical University Munich, Klinikum Rechts Der Isar, Munich, Germany., Addala A; Division of Endocrinology, Department of Pediatrics, Stanford University School of Medicine, Stanford, CA, USA.; Stanford Diabetes Research Center, Stanford University School of Medicine, Stanford, CA, USA., Albanese-O'Neill A; Breakthrough T1D, Gainesville, FL, USA. aaoneill@breakthrought1d.org., Battelino T; Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia.; Department of Endocrinology, Diabetes and Metabolism, University Medical Centre Ljubljana, Ljubljana, Slovenia., Bell KJ; Charles Perkins Centre and Faculty of Medicine and Health, University of Sydney, Sydney, NSW, Australia., Besser REJ; JDRF/Wellcome Diabetes and Inflammation Laboratory, Wellcome Centre Human Genetics, Nuffield Department of Medicine Oxford NIHR Biomedical Research Centre, University of Oxford, Oxford, UK.; Department of Paediatrics, University of Oxford, Oxford, UK., Bonifacio E; Center for Regenerative Therapies Dresden, Faculty of Medicine, Technical University of Dresden, Dresden, Germany.; Paul Langerhans Institute Dresden, Helmholtz Centre Munich at the University Clinic Carl Gustav Carus of TU Dresden and Faculty of Medicine, Dresden, Germany., Colhoun HM; The Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, UK.; Department of Public Health, NHS Fife, Kirkcaldy, UK., Couper JJ; Robinson Research Institute, The University of Adelaide, Adelaide, SA, Australia.; Adelaide Medical School, The University of Adelaide, Adelaide, SA, Australia.; Division of Paediatrics, Women's and Children's Hospital, Adelaide, SA, Australia., Craig ME; Charles Perkins Centre and Faculty of Medicine and Health, University of Sydney, Sydney, NSW, Australia.; Discipline of Paediatrics & Child Health, School of Clinical Medicine, UNSW Medicine & Health, Sydney, NSW, Australia., Danne T; Breakthrough T1D, Lisbon, Portugal., de Beaufort C; International Society for Pediatric and Adolescent Diabetes (ISPAD), Berlin, Germany.; Diabetes & Endocrine Care Clinique Pediatrique (DECCP), Clinique Pediatrique/Centre Hospitalier (CH) de Luxembourg, Luxembourg City, Luxembourg.; Faculty of Science, Technology and Medicine, University of Luxembourg, Esch‑Belval, Luxembourg., Dovc K; Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia.; Department of Endocrinology, Diabetes and Metabolism, University Medical Centre Ljubljana, Ljubljana, Slovenia., Driscoll KA; Department of Pediatrics, Barbara Davis Center for Diabetes, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.; Department of Clinical and Health Psychology, University of Florida, Gainesville, FL, USA.; Department of Pediatrics, University of Florida Diabetes Institute, Gainesville, FL, USA., Dutta S; Breakthrough T1D, New York, NY, USA., Ebekozien O; T1D Exchange, Boston, MA, USA., Larsson HE; Department of Clinical Sciences, Malmo, Lund University, Lund, Sweden.; Department of Pediatrics, Skane University Hospital, Malmo and Lund, Sweden., Feiten DJ; Children's Diabetes Foundation, Aurora, CO, USA., Frohnert BI; Department of Pediatrics, Barbara Davis Center for Diabetes, University of Colorado Anschutz Medical Campus, Aurora, CO, USA., Gabbay RA; American Diabetes Association, Arlington, VA, USA., Gallagher MP; NYU Langone Medical Center, New York, NY, USA., Greenbaum CJ; Center for Interventional Immunology and Diabetes Program, Benaroya Research Institute, Seattle, WA, USA., Griffin KJ; Sanford Research, Sioux Falls, SD, USA.; Department of Pediatrics, Sanford School of Medicine, University of South Dakota, Sioux Falls, SD, USA., Hagopian W; Pacific Northwest Diabetes Research Institute, University of Washington, Seattle, WA, USA., Haller MJ; Department of Pediatrics, University of Florida Diabetes Institute, Gainesville, FL, USA.; Division of Endocrinology, University of Florida College of Medicine, Gainesville, FL, USA., Hendrieckx C; School of Psychology, Deakin University, Geelong, VIC, Australia.; The Australian Centre for Behavioural Research in Diabetes, Diabetes Victoria, Carlton, VIC, Australia.; Institute for Health Transformation, Deakin University, Geelong, VIC, Australia., Hendriks E; Department of Paediatrics, University of Cambridge and Cambridge University Hospitals NHS Foundation Trust, Cambridge Biomedical Campus, Cambridge, UK., Holt RIG; Human Development and Health, Faculty of Medicine, University of Southampton, Southampton, UK.; National Institute for Health and Care Research Biomedical Research Centre, University Hospital Southampton NHS Foundation Trust, Southampton, UK., Hughes L; Mount Sinai South Nassau, Oceanside, NY, USA., Ismail HM; Department of Pediatrics, Indiana University School of Medicine, Indianapolis, IN, USA., Jacobsen LM; Division of Endocrinology, University of Florida College of Medicine, Gainesville, FL, USA., Johnson SB; Department of Behavioral Sciences and Social Medicine, Florida State University College of Medicine, Tallahassee, FL, USA., Kolb LE; Association of Diabetes Care & Education Specialists, Chicago, IL, USA., Kordonouri O; Breakthrough T1D, Lisbon, Portugal., Lange K; Medical Psychology, Hannover Medical School, Hannover, Germany., Lash RW; Endocrine Society, Washington, DC, USA., Lernmark Å; Department of Clinical Sciences, Malmo, Lund University, Lund, Sweden., Libman I; Division of Pediatric Endocrinology and Diabetes, University of Pittsburgh, UPMC Children's Hospital of Pittsburgh, Pittsburgh, PA, USA., Lundgren M; Department of Clinical Sciences, Malmo, Lund University, Lund, Sweden.; Department of Pediatrics, Kristianstad Hospital, Kristianstad, Sweden., Maahs DM; Division of Endocrinology, Department of Pediatrics, Stanford University School of Medicine, Stanford, CA, USA., Marcovecchio ML; Department of Pediatrics, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK., Mathieu C; Department of Endocrinology, UZ Gasthuisberg, KU Leuven, Leuven, Belgium., Miller KM; T1D Exchange, Boston, MA, USA., O'Donnell HK; Department of Pediatrics, Barbara Davis Center for Diabetes, University of Colorado Anschutz Medical Campus, Aurora, CO, USA., Oron T; Institute for Endocrinology and Diabetes, National Center for Childhood Diabetes, Schneider Children's Medical Center of Israel, Petah Tikva, Israel.; Faculty of Medical and Health Sciences, Tel Aviv University, Tel Aviv, Israel., Patil SP; Department of Family Medicine, Brody School of Medicine, East Carolina University, Greenville, NC, USA., Pop-Busui R; Department of Internal Medicine, Division of Metabolism, Endocrinology and Diabetes, University of Michigan, Ann Arbor, MI, USA., Rewers MJ; Department of Pediatrics, Barbara Davis Center for Diabetes, University of Colorado Anschutz Medical Campus, Aurora, CO, USA., Rich SS; Center for Public Health Genomics, University of Virginia, Charlottesville, VA, USA., Schatz DA; Department of Pediatrics, University of Florida, Gainesville, FL, USA., Schulman-Rosenbaum R; Division of Endocrinology, Long Island Jewish Medical Center, Northwell Health, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, New Hyde Park, NY, USA., Simmons KM; Department of Pediatrics, Barbara Davis Center for Diabetes, University of Colorado Anschutz Medical Campus, Aurora, CO, USA., Sims EK; Division of Pediatric Endocrinology and Diabetology, Herman B Wells Center for Pediatric Research, Center for Diabetes and Metabolic Diseases, Indiana University School of Medicine, Indianapolis, IN, USA., Skyler JS; Diabetes Research Institute, University of Miami Miller School of Medicine, Miami, FL, USA., Smith LB; Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA., Speake C; Center for Interventional Immunology and Diabetes Program, Benaroya Research Institute, Seattle, WA, USA., Steck AK; Department of Pediatrics, Barbara Davis Center for Diabetes, University of Colorado Anschutz Medical Campus, Aurora, CO, USA., Thomas NPB; NIHR Clinical Research Network Thames Valley and South Midlands, Oxford, UK., Tonyushkina KN; Division of Endocrinology and Diabetes, Baystate Children's Hospital and University of Massachusetts Chan Medical School - Baystate, Springfield, MA, USA., Veijola R; Research Unit of Clinical Medicine, Department of Pediatrics, Medical Research Center, Oulu University Hospital and University of Oulu, Oulu, Finland., Wentworth JM; The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia.; Department of Diabetes and Endocrinology, Royal Melbourne Hospital, Parkville, VIC, Australia., Wherrett DK; Department of Paediatrics, The Hospital for Sick Children, University of Toronto, Toronto, ON, Canada., Wood JR; Department of Pediatric Endocrinology, Rainbow Babies and Children's Hospital, University Hospitals Cleveland Medical Center, Cleveland, OH, USA., Ziegler AG; Institute of Diabetes Research, Helmholtz Zentrum Munchen, German Research Center for Environmental Health, Munich‑Neuherberg, Germany.; Forschergruppe Diabetes, Technical University Munich, Klinikum Rechts Der Isar, Munich, Germany., DiMeglio LA; Department of Pediatrics, Indiana University School of Medicine, Indianapolis, IN, USA.

Publikováno v: Diabetologia [Diabetologia] 2024 Sep; Vol. 67 (9), pp. 2012-2014.